Hyponatremia associated with repeated use of levetiracetam

被引：26

作者：

Nasrallah, K ^{[1
]}

Silver, B ^{[1
]}

机构：

[1] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA

来源：

EPILEPSIA | 2005年 / 46卷 / 06期

关键词：

levetiracetam; hyponatremia; SIADH; carbamazepine;

D O I：

10.1111/j.1528-1167.2005.64004.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Levetiracetam (LEV) is increasingly used as adjunctive anticonvulsant therapy because of apparent low toxicity. Somnolence, asthenia, headache, dizziness, and nervousness are the most frequently reported side effects (1). We describe a patient, predisposed to the development of the syndrome of inappropriate antidiuretic hormone secretion (SIADH), in whom hyponatremia developed after two challenges of LEV.

引用

页码：972 / 973

页数：2

共 5 条

[1]

Arroyo S, 2003, EPILEPTIC DISORD, V5, pS57

[2] The new antiepileptic drugs: A systematic review of their efficacy and tolerability [J].